Amy Kogon, MD, MPH
Amy Kogon, MD, MPH

Amy Kogon, MD, MPH

Amy Kogon, MD, MPH, is an attending physician in the Division of Nephrology at Children's Hospital of Philadelphia.

Areas of expertise: Kidney Transplantation, Dialysis, Chronic kidney disease and its complication in children, Hypertension in chronic kidney disease, Psychosocial and neurocognitive complications of chronic kidney diseases (CKD)

Locations: Buerger Center for Advanced Pediatric Care, Specialty Care, King of Prussia

Make an appointment

215-590-2449

215-590-4600

About Amy Kogon, MD, MPH

Titles

Attending Physician

Assistant Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania

Leadership and Memberships
Memberships in Professional Organizations

American Society of Pediatric Nephrology
American Society of Nephrology

Research Interests

Psychosocial and neurocognitive complications of CKD Hypertension in chronic kidney disease Glomerulonephritis-cure GN

Education & training

Medical Degree

MD - University of Pennsylvania, Philadelphia, PA

Residency

St. Louis Children's Hospital, St. Louis, MO

Fellowship

Seattle Children's Hospital, Seattle, WA

Team affiliations

 View fewer all team affiliations View all all team affiliations

Publications

Publications

2019

Kogon AJ, Kim JY, Laney N, Radcliffe J, Hooper SR, Furth SL, Hartung EA.. Depression and neurocognitive dysfunction in pediatric and young adult chronic kidney disease.   2019 May 2. doi: 10.1007/s00467-019-04265-z. Pediatr Nephrol., May 2019. doi: 10.1007/s00467-019-04265-z. [Epub ahead of print]

2018

Harshman Lyndsay A, Johnson Rebecca J, Matheson Matthew B, Kogon Amy J, Shinnar Shlomo, Gerson Arlene C, Warady Bradley A, Furth Susan L, Hooper Stephen R. Academic achievement in children with chronic kidney disease: a report from the CKiD cohort. Pediatric nephrology, Nov 2018. [Epub ahead of print]

2017

Knight A, Kogon AJ, Matheson MB, Warady BA, Furth SL, Hooper SR. Cognitive Function in Children with Lupus Nephritis: A Cross-Sectional Comparison with Children with Other Glomerular Chronic Kidney Diseases.J Pediatr. 2017 Oct; 189: 181-188.

Akchurin OM, Kogon AJ, Sethna CB, Hammad HT, Christos PJ, Mahan JD, Greenbaum LA, Woroniecki R. Approach to growth hormone therapy in children with chronic kidney disease varies across North America: the Midwest Pediatric Nephrology Conso11ium report. BMC Nephrol. 2017 May 30;18(1)

Verbitsky M, Kogon AJ, Matheson MB, Hooper SR, Wong CS, Warady BA, Furth SL, Gharavi AG. Genomic Disorders and Neurocognitive Impairment in Pediatric Chronic Kidney Disease. J Am Soc Nephrol. 2017 Aug;28(8):2303-2309.

2016

Kogon AJ, Matheson MB, Flynn JT, Gerson AC, Warady BA, Furth SL Hooper SR, Chronic Kidney Disease in Children Study Group. Depressive symptoms in children with chronic kidney disease. J Pediatr 2016; 168: 164-170.

2014

Kogon AJ, Pierce CB, Cox C, Brady TM, Mitsnefes MM, Warady BA, Furth SL, Flynn JT. Nephrotic-range proteinuria is strongly associated with poor blood pressure control in pediatric chronic kidney disease. Kidney Int 2014; 85(4):938-44.

2013

Kogon AJ, Van der Stoep A, Weiss NS, Flynn JT, Smith J, McCauley EM. Depression and its associated factors in pediatric chronic kidney disease. Pediatric Nephrology 2013; 28(9): 1855-61.

2010

Kogon A, Hingorani S. Acute Kidney Injury in Hematopoietic Cell Transplantation. Seminars in Nephrology 2010; 50 (6): 615-626.

2008

Metjian TA, Prasad PA, Kogon A, Coffin SE, Zaoutis TE. Evaluation of an Antimicrobial Stewardship Program (ASP) at a Pediatric Teaching Hospital. Pediatric Infectious Diseases Journal 2008; 27(2): 106-11.

2003

Lee JA, Parrett BM, Conejero JA, Laser J, Chen J, Kogon A, Grant RT, and Breitbart AS. Biological alchemy: engineering bone and fat from fat-derived stem cells. Annals of Plastic Surgery 2003; 50:610-617.

2001

Breitbart AS, Nanda DA Laser J, Barcia M, Porti D, Malhotra S, Kogon AJ, Grant RT, Mason JM. Treatment of ischemic wounds using cultured dermal fibroblasts transduced retrovirally with PDGF-B and VEGF121 genes. Annals of Plastic Surgery 2001; 46(5):555-61

Patient experience rating

(based on 31 submissions)
  • Clear Explanation
    4.8 of 5
  • Showed Concern
    4.9 of 5
  • Included in decisions
    4.8 of 5
  • Would recommend
    4.7 of 5
  • Discussion of Proposed Treatment
    4.8 of 5
Learn about the patient experience rating system

About the Patient Experience Rating System

The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question. Responses are measured on a scale of 1 to 5 with 5 being the best score. We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient’s protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments. Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care. The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.